New OTC eczema cream under microscope: can it soothe Flare-Ups?
NCT ID NCT07146971
First seen Apr 17, 2026 · Last updated May 06, 2026 · Updated 4 times
Summary
This early-stage study tests an over-the-counter drug for atopic dermatitis (eczema) in 36 adults with active flare-ups. Researchers will check how the drug affects skin bacteria, hydration, and barrier function. The goal is to see if the product can ease symptoms like itching and redness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sequential Skin
RECRUITINGNew York, New York, 10013, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.